Recursive Partitioning vs Computerized Adaptive Testing to Reduce the Burden of Health Assessments in Cleft Lip and/or Palate: Comparative Simulation Study.

CLEFT-Q cleft Lip cleft palate computerized adaptive test decision tree machine learning outcome assessment patient-reported outcome measures regression tree

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
30 07 2021
Historique:
received: 10 12 2020
accepted: 24 05 2021
revised: 25 02 2021
entrez: 30 7 2021
pubmed: 31 7 2021
medline: 26 10 2021
Statut: epublish

Résumé

Computerized adaptive testing (CAT) has been shown to deliver short, accurate, and personalized versions of the CLEFT-Q patient-reported outcome measure for children and young adults born with a cleft lip and/or palate. Decision trees may integrate clinician-reported data (eg, age, gender, cleft type, and planned treatments) to make these assessments even shorter and more accurate. We aimed to create decision tree models incorporating clinician-reported data into adaptive CLEFT-Q assessments and compare their accuracy to traditional CAT models. We used relevant clinician-reported data and patient-reported item responses from the CLEFT-Q field test to train and test decision tree models using recursive partitioning. We compared the prediction accuracy of decision trees to CAT assessments of similar length. Participant scores from the full-length questionnaire were used as ground truth. Accuracy was assessed through Pearson's correlation coefficient of predicted and ground truth scores, mean absolute error, root mean squared error, and a two-tailed Wilcoxon signed-rank test comparing squared error. Decision trees demonstrated poorer accuracy than CAT comparators and generally made data splits based on item responses rather than clinician-reported data. When predicting CLEFT-Q scores, individual item responses are generally more informative than clinician-reported data. Decision trees that make binary splits are at risk of underfitting polytomous patient-reported outcome measure data and demonstrated poorer performance than CATs in this study.

Sections du résumé

BACKGROUND
Computerized adaptive testing (CAT) has been shown to deliver short, accurate, and personalized versions of the CLEFT-Q patient-reported outcome measure for children and young adults born with a cleft lip and/or palate. Decision trees may integrate clinician-reported data (eg, age, gender, cleft type, and planned treatments) to make these assessments even shorter and more accurate.
OBJECTIVE
We aimed to create decision tree models incorporating clinician-reported data into adaptive CLEFT-Q assessments and compare their accuracy to traditional CAT models.
METHODS
We used relevant clinician-reported data and patient-reported item responses from the CLEFT-Q field test to train and test decision tree models using recursive partitioning. We compared the prediction accuracy of decision trees to CAT assessments of similar length. Participant scores from the full-length questionnaire were used as ground truth. Accuracy was assessed through Pearson's correlation coefficient of predicted and ground truth scores, mean absolute error, root mean squared error, and a two-tailed Wilcoxon signed-rank test comparing squared error.
RESULTS
Decision trees demonstrated poorer accuracy than CAT comparators and generally made data splits based on item responses rather than clinician-reported data.
CONCLUSIONS
When predicting CLEFT-Q scores, individual item responses are generally more informative than clinician-reported data. Decision trees that make binary splits are at risk of underfitting polytomous patient-reported outcome measure data and demonstrated poorer performance than CATs in this study.

Identifiants

pubmed: 34328443
pii: v23i7e26412
doi: 10.2196/26412
pmc: PMC8367147
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26412

Subventions

Organisme : CIHR
ID : FRN-130515
Pays : Canada

Informations de copyright

©Conrad J Harrison, Chris J Sidey-Gibbons, Anne F Klassen, Karen W Y Wong Riff, Dominic Furniss, Marc C Swan, Jeremy N Rodrigues. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 30.07.2021.

Références

J Plast Reconstr Aesthet Surg. 2019 Dec;72(12):2049-2055
pubmed: 31488380
Disabil Rehabil. 2020 Sep;42(19):2758-2765
pubmed: 30739531
Emerg Themes Epidemiol. 2017 Sep 20;14:11
pubmed: 28943885
Patient Prefer Adherence. 2018 Jun 19;12:1043-1053
pubmed: 29950817
Plast Reconstr Surg. 2019 Jul;144(1):78e-88e
pubmed: 31246826
J Affect Disord. 2016 Dec;206:204-209
pubmed: 27475891
Arch Phys Med Rehabil. 2019 Dec;100(12):2308-2313
pubmed: 31181179
Patient. 2014;7(1):23-35
pubmed: 24403095
BMJ Open. 2017 Jan 11;7(1):e015467
pubmed: 28077415
CMAJ. 2018 Apr 16;190(15):E455-E462
pubmed: 29661814
Lancet. 2009 Nov 21;374(9703):1773-85
pubmed: 19747722

Auteurs

Conrad J Harrison (CJ)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.

Chris J Sidey-Gibbons (CJ)

MD Anderson Center for INSPiRED Cancer Care, University of Texas, Houston, TX, United States.

Anne F Klassen (AF)

Department of Pediatrics, McMaster University, Hamilton, ON, Canada.

Karen W Y Wong Riff (KWY)

Department of Plastic and Reconstructive Surgery, Hospital for Sick Children, Toronto, ON, Canada.

Dominic Furniss (D)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.

Marc C Swan (MC)

Spires Cleft Centre, John Radcliffe Hospital, Oxford, United Kingdom.

Jeremy N Rodrigues (JN)

Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom.
Department of Plastic Surgery, Stoke Mandeville Hospital, Buckinghamshire Healthcare NHS Trust, Aylesbury, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH